Strengthen your portfolio by making more informed decisions and prepare for the impact of new research discoveries.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSIn recent years, the field of RNA therapeutics has evolved as a ground-breaking approach in medical research. Notably, the 2023 Nobel Prize in Physiology or Medicine was awarded for groundbreaking work on base modification, a critical discovery that enabled the development of COVID-19 vaccines. Following this achievement, focus has now turned to leveraging RNA's intrinsic immune-activating potential for oncology, with mRNA therapies taking the lead. mRNA therapies offer unique benefits over conventional therapies like recombinant proteins and plasmid DNA, including non-integrating, cell-free production, enhanced specificity, and potency, as well as a personalized, patient-focused approach.
Additionally, mRNA therapies possess ability to target undruggable targets with minimal side effects, setting them apart from conventional approaches. Few mRNA therapies are entering late-stage clinical development, including, Gritstone bio's GRANITE and Moderna's personalized cancer vaccine mRNA-4157, which are leading the way and are expected to enter the market in Q2 2027 and Q3 2030 respectively, according to IQVIA Pipeline Link.
This article provides an update on current mRNA based therapies for oncology and outlines the latest development activities, including ongoing clinical trials of key experimental drugs with data sourced from IQVIA Pipeline Link and IQVIA Trial Link.
Download the article for more details and to explore the latest advancements in RNA therapeutics and their impact on cancer treatment in our article. Learn about the benefits of mRNA therapies, key developments, and ongoing clinical trials.
Strengthen your portfolio by making more informed decisions and prepare for the impact of new research discoveries.
IQVIA Analytics Link Ecosystem establishes deep connections across our key data assets.